Coeptis Therapeutics Holdings, Inc. (ZSQR) Stock Analysis & Investment Frameworks
Coeptis Therapeutics Holdings, Inc. (ZSQR) stock analysis on Invetso. Review Coeptis Therapeutics Holdings, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Coeptis Therapeutics Holdings, Inc. Company Overview
- Exchange: NASDAQ Global Market
- Sector: Technology
- Industry: Software - Services
- Country: US
Coeptis Therapeutics Holdings, Inc. Key Financial Metrics
- Market Cap: $213.86M
- Revenue: $1.36M
- ROE: -47.98%
- ROIC: -16.45%
- Dividend Yield: N/A
About Coeptis Therapeutics Holdings, Inc.
Z Squared Inc. operates as an integrated computing infrastructure company, deploying and managing advanced computing equipment across its facilities in North Carolina, South Carolina, and Iowa. The firm diligently oversees and optimizes its extensive network of specialized hardware. This comprehensive approach incorporates dynamic power management strategies, real-time analytics dashboards for performance monitoring, and an internal program dedicated to repair and lifecycle management. These measures collectively aim to maximize the operational efficiency of their hardware assets and minimize capital expenditure. Established in 2022, Z Squared Inc. has its corporate base in Fort Lauderdale, Florida.
Coeptis Therapeutics Holdings, Inc. Investment Frameworks
Invetso analyzes Coeptis Therapeutics Holdings, Inc. (ZSQR) across the following frameworks:
- Coeptis Therapeutics Holdings, Inc. 10Y Growth Potential
- Coeptis Therapeutics Holdings, Inc. Scenario Analysis
- Coeptis Therapeutics Holdings, Inc. Risks & Opportunities
- Coeptis Therapeutics Holdings, Inc. Economic Moat
- Coeptis Therapeutics Holdings, Inc. Business Model
- Coeptis Therapeutics Holdings, Inc. Management
- Coeptis Therapeutics Holdings, Inc. SWOT Analysis
- Coeptis Therapeutics Holdings, Inc. Porter's 5 Forces
- Coeptis Therapeutics Holdings, Inc. PESTLE Analysis
- Coeptis Therapeutics Holdings, Inc. ESG Analysis